C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01)
Patent
CA 2707539
The present invention relates to oligomer compounds (oligomers), which target PIK3CA mRNA in a cell, leading to reduced expression of PIK3CA. Reduction of PIK3CA expression is beneficial for the treatment of certain medical disorders, such as hyperproliferative diseases such as cancer.
La présente invention concerne des composés d'oligomères (oligomères) qui ciblent l'ARNm PIK3CA dans une cellule, ce qui entraîne ainsi une expression réduite de PIK3CA. La réduction de l'expression de PIK3CA est bénéfique pour le traitement de certains troubles médicaux, tels que les maladies hyperprolifératives comme le cancer.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Enzon Pharmaceuticals Inc.
Santaris Pharma A/s
LandOfFree
Rna antagonist compounds for the modulation of pik3ca... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rna antagonist compounds for the modulation of pik3ca..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rna antagonist compounds for the modulation of pik3ca... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1742303